Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Mahner

Showing results (261-270 of 455) with videos related to

Pageof 46
Sort By:
Journal of Cancer Research and Clinical Oncology|November 27, 2022
Prostaglandin E2 receptor EP1 expression in vulvar cancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Radiation Oncology (London, England)|February 11, 2018
Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 casesStefanie Corradini, Montserrat Pazos, Stephan Schönecker, et al.
Breast Cancer (Tokyo, Japan)|May 18, 2023
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitroLili Lin, Kristina Pfender, Nina Ditsch, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2012
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysisSven Mahner, Gülten Oskay-Özcelik, Elke Heidrich-Lorsbach, et al.
Archives of Gynecology and Obstetrics|March 29, 2025
PROM at term: when might be the best time to induce labour? A retrospective analysisTeresa Starrach, Lucia Ehmann, Hannah Volkmann, et al.
Histochemistry and Cell Biology|June 24, 2020
Cytoplasmic VDR expression as an independent risk factor for ovarian cancerBastian Czogalla, Eileen Deuster, Yue Liao, et al.
Archives of Gynecology and Obstetrics|March 12, 2025
Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancerLukas Chinczewski, Philipp Harter, Lukas Heukamp, et al.
Oncotarget|December 30, 2017
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancerAurelia Vattai, Vincent Cavailles, Sophie Sixou, et al.
Cancers|December 10, 2021
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Elena Ioana Braicu, Stephan Polterauer, et al.
Archives of Gynecology and Obstetrics|September 6, 2022
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in GermanyLucia Keilmann, Susanne Beyer, Sarah Meister, et al.
Pageof 46

Showing results (261-270 of 455) with videos related to

Sort By:
Pageof 46
Journal of Cancer Research and Clinical Oncology|November 27, 2022
Prostaglandin E2 receptor EP1 expression in vulvar cancerAnna Buchholz, Aurelia Vattai, Sophie Fürst, et al.
Radiation Oncology (London, England)|February 11, 2018
Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: an observational study of 1048 casesStefanie Corradini, Montserrat Pazos, Stephan Schönecker, et al.
Breast Cancer (Tokyo, Japan)|May 18, 2023
KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitroLili Lin, Kristina Pfender, Nina Ditsch, et al.
Journal of Cancer Research and Clinical Oncology|April 25, 2012
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysisSven Mahner, Gülten Oskay-Özcelik, Elke Heidrich-Lorsbach, et al.
Archives of Gynecology and Obstetrics|March 29, 2025
PROM at term: when might be the best time to induce labour? A retrospective analysisTeresa Starrach, Lucia Ehmann, Hannah Volkmann, et al.
Histochemistry and Cell Biology|June 24, 2020
Cytoplasmic VDR expression as an independent risk factor for ovarian cancerBastian Czogalla, Eileen Deuster, Yue Liao, et al.
Archives of Gynecology and Obstetrics|March 12, 2025
Intergroup-statement: statement of the german ovarian cancer commission, the North-Eastern German Society of gynecological Oncology (NOGGO), AGO Austria and AGO Swiss regarding the use of homologous repair deficiency (HRD) assays in advanced ovarian cancerLukas Chinczewski, Philipp Harter, Lukas Heukamp, et al.
Oncotarget|December 30, 2017
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancerAurelia Vattai, Vincent Cavailles, Sophie Sixou, et al.
Cancers|December 10, 2021
Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer-A Study of the OVCAD ConsortiumEva Obermayr, Elena Ioana Braicu, Stephan Polterauer, et al.
Archives of Gynecology and Obstetrics|September 6, 2022
Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in GermanyLucia Keilmann, Susanne Beyer, Sarah Meister, et al.
Pageof 46